The effect of heat‐killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non‐alcoholic fatty liver disease mice without altering the gut microbiota
Hidemi Hayashi, Koji Sawada, Hiroki Tanaka, Kazuki Muro, Takumu Hasebe, Shunsuke Nakajima, Toshikatsu Okumura, Mikihiro Fujiya- Gastroenterology
- Hepatology
Abstract
Background and Aim
There have been several reports that some probiotics improve non‐alcoholic fatty liver disease (NAFLD); however, many studies have involved cocktail therapies. We evaluated whether heat‐killed
Methods
The NAFLD model was induced in mice fed a high‐fat diet (HFD) (HFD mice) or HFD + 1% heat‐killed
Results
Histopathological findings revealed that fat droplets in the liver were significantly reduced in SBL mice; however, terminal restriction fragment length polymorphism did not show alterations in the gut microbiota between HFD mice and SBL mice. RNA sequencing and pathway analysis revealed that the regulation of lipid and insulin metabolism was affected. The mRNA expression of insulin receptor substrate 2 (IRS‐2) was significantly higher in SBL mice, whereas the expression of IRS‐1 was not significantly different. Phospho‐IRS‐2 expression was also significantly increased in SBL mice. In addition, an in vitro study revealed significant alterations in IRS‐2 and forkhead box protein O1 expression levels.
Conclusion
SBL mice exhibited partially improved selective hepatic insulin resistance. Our data suggest that heat‐killed